Vincerx Pharma stock rises 64% after proposing merger with Oqory, retail investors positive.

From StockTwits: 2024-12-30 01:14:32

Retail sentiment on Stocktwits has remained ‘bullish’ on Vincerx Pharma ($VINC) following its proposed merger with Oqory. Shares surged 64% in after-hours trading on Friday. Oqory equity holders are expected to own 95% of the combined entity post-merger. Vincerx plans to cut its workforce and reduce costs, with CEO Dr. Ahmed Hamdy stepping down. Dr. Raquel Izumi is now acting CEO. The merger is subject to closing conditions and requires at least $20 million in financing. The deal values existing Vincerx stockholders at $13.66 million. Additional financing of $1.5 million will be provided by designated investors.



Read more at StockTwits: Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish